InsidersTradesSigma
Browse the full record of transactions filed by Floyd Eric, Director. Officer active across 1 companies, notably Virpax Pharmaceuticals, Inc.. Cumulatively, 1 reports have been recorded. Total volume traded: €6k. The latest transaction was disclosed on 18 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration
Floyd Eric is a Director at Virpax Pharmaceuticals, Inc. He plays a key role in the governance of the company, participating in strategic decisions and ensuring compliance with industry standards. His experience in the pharmaceutical sector is valuable in guiding growth initiatives.